Aclaris Therapeutics, Inc. Purchase Agreements
5 Contracts & Agreements
- Royalty Purchase Agreement, effective as of July 16, 2024, by and between the Registrant and OCM IP Healthcare Portfolio LP (Filed With SEC on August 7, 2024)
- Purchase Agreement, dated as of August 13, 2020, by and between the Company and Lincoln Park (Filed With SEC on August 13, 2020)
- Asset Purchase Agreement, by and between the Company and EPI Health, LLC, dated as of October 10, 2019 (Filed With SEC on October 11, 2019)
- Asset Purchase Agreement, by and between the Company and Allergan Sales, LLC, dated as of October 15, 2018, as amended on November 30, 2018 (Filed With SEC on December 3, 2018)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 2, 2016)
